Price
No data yet.
Social Signal Score
Revenue
$750.16MCompany Profile
- CEO
- Andrew Regan
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 4
- Beta
- 1.49
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 1.44
Financials
Revenue
$750.16M+7.7%Net Income
$68.54MEBITDA
$159.66MFree Cash Flow
$2.08MEPS (diluted)
$1.74Shares Outstanding (diluted)
39.34M+6827339.6%Operating Expenses
$183.66MCash & Debt
$348.65MReturn of Capital
$32.33MRevenue by Segment (annual)
$1.32BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-39.22M | $-117.79 |
| 2024 | $0.00 | $-17.80M | $-6159.30 |
| 2023 | $0.00 | $-535.0K | $-239.70 |
| 2022 | $0.00 | $-4.89M | $-2013.60 |
| 2021 | $0.00 | $-3.66M | $-7.50 |
Valuation
CDThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80Social Signal Score
Mentions (1)
- Newsglobenewswire.com·6h ago·Negative
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has entered into a SAFE note with Pep'd Inc. (“Pep'd”), a US-based peptide company, expanding CDT's exposure to the growing US peptide market (the “Transaction”).
View source ↗
Insider trading
Open-market buys and sells by CDT officers and directors.
- Bought
- $625k
- Sold
- $8.9m
1 trade
21 trades
- Taylor Mark Andrewsold
- Taylor Mark Andrewsold
- Taylor Mark Andrewsold
- Taylor Mark Andrewsold
- Nirland Ltdsold
- Nirland Ltdsold
- Nirland Ltdsold
- Nirland Ltdsold
78 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.